NCT04148573 - Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

May 20, 2022

Study Completion Date

July 20, 2022

Conditions

Neuropathic PainSpinal Cord Injuries

Interventions

DRUG

NFX88 - 1

3 times a day

DRUG

NFX88 - 2

3 times a day

DRUG

NFX88 - 3

3 times a day

DRUG

PLACEBO - 4

3 times a day

Trial Locations (7)

Hospital de paraplegicos de Toledo, Toledo

Complejo Hospitalario Universitario A Coruña, A Coruña

Hospital Vall de Hebron, Barcelona

Instituto Guttmann, Barcelona

Hospital Virgen de las Nieves, Granada

Hospital los Madroños, Madrid

Hospital Virgen del Rocio, Seville